financetom
Business
financetom
/
Business
/
AST SpaceMobile Signs Agreement for Lower Mid-Band Spectrum Access in US
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AST SpaceMobile Signs Agreement for Lower Mid-Band Spectrum Access in US
Jan 6, 2025 8:22 AM

11:07 AM EST, 01/06/2025 (MT Newswires) -- AST SpaceMobile ( ASTS ) said Monday it signed an agreement for long-term access to up to 45 MHz of lower mid-band spectrum in the US for direct-to-device satellite applications.

AST said it will receive spectrum usage rights for over 80 years to up to 40 MHz of L-Band MSS spectrum in the US and Canada held by Ligado under the deal, plus access to an additional 5 MHz in the 1670-1675 MHz Band in the US.

The deal is subject to the entry into definitive documentation, which is expected in H1, the firm said. The transaction is part of Ligado's ongoing restructuring.

Ligado will get about 4.7 million penny warrants convertible into AST class A shares, subject to a 12-month lock-up, the company said, adding that Ligado will get an additional consideration of about $550 million upon deal closing.

The firm said it would also pay about $80 million a year for spectrum usage rights and provide Ligado with net revenue sharing rights.

AST said it could boost the potential of its in-orbit network, expanding subscriber capacity while enabling peak data transmission speeds up to 120 Mbps to smartphones in the US with its 3GPP spectrum strategy and the new access.

Price: 24.52, Change: +0.55, Percent Change: +2.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Chesswood Group Drops 30% After Putting Itself Up for Sale Following a Strategic Review
Update: Chesswood Group Drops 30% After Putting Itself Up for Sale Following a Strategic Review
Jun 17, 2024
11:56 AM EDT, 06/17/2024 (MT Newswires) -- Chesswood Group ( CHWWF ) , a specialty finance company, late on Friday said it decided to pursue the sale of the company or some of its units following the end of a strategic review. Several parties have shown interest in acquiring Chesswood ( CHWWF ) or some of its business units, the...
Church & Dwight Insider Sold Shares Worth $266,778, According to a Recent SEC Filing
Church & Dwight Insider Sold Shares Worth $266,778, According to a Recent SEC Filing
Jun 17, 2024
11:50 AM EDT, 06/17/2024 (MT Newswires) -- Carlen Hooker, Executive Vice President, Chief Commercial Officer, on June 14, 2024, sold 2,500 shares in Church & Dwight ( CHD ) for $266,778. Following the Form 4 filing with the SEC, Hooker has control over a total of 723 shares of the company, with 580 shares held directly and 143 controlled indirectly....
Broadridge Expands Futures, Options Trading Platform with Addition of Transaction Network Services Infrastructure
Broadridge Expands Futures, Options Trading Platform with Addition of Transaction Network Services Infrastructure
Jun 17, 2024
11:52 AM EDT, 06/17/2024 (MT Newswires) -- Broadridge Financial Solutions ( BR ) said Monday it was combining its global futures and options software-as-a-service platform with its Transaction Network Services infrastructure for the financial markets. According to the company, the addition of transaction network services are expected to enhance the functionality of Broadridge's futures and options platform for the derivatives...
Charles River Laboratories, Captain T Cell Enter Manufacturing Deal
Charles River Laboratories, Captain T Cell Enter Manufacturing Deal
Jun 17, 2024
11:58 AM EDT, 06/17/2024 (MT Newswires) -- Charles River Laboratories ( CRL ) and Captain T Cell said Monday that they have entered into a plasmid DNA and retrovirus vector production program deal. Captain T Cell will use plasmid and viral vector contract development and manufacturing organization services under Charles River's cell and gene therapy accelerator program, the companies said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved